The 2018 Farm Bill paved the way for the introduction of cannabis into the market, although slowly. It all started with CBD, which quickly became a popular alternative therapeutic option. We now have CBG, CBN, THCV, delta 8, delta 10, HHC, and so on… we’ve lost track. Here’s all you need to know about CBC: what it is, what it does, what makes it special, and how to get it.

Click here for more information.


The third most abundant cannabinoid in cannabis is cannabichromene or CBC. It’s right up there with CBD and THC in terms of potency. CBG is the source of all three cannabinoids, albeit, in hemp and marijuana, the majority of the CBG is converted to CBD or THC. Although we’ve known about CBC for decades — since 1966, to be exact — producers have traditionally bred these plants for high levels of CBD and THC, respectively.

Thanks to the Farm Bill or the discovery of the endocannabinoid system, we now have a renewed interest in cannabinoids like CBC and their impact on the human body. Breeders have shifted their efforts to develop new, CBC-rich cannabis as a result of this desire. Realistically, we’ll have to wait a few more years for any measurable findings. For the time being, CBC is isolated from hemp plants & concentrated using chromatography and distillation.


Without a science dictionary and a lot of spare time, the following material could not mean anything to you unless you have a degree or a passion for this topic.

We include this material to give context to CBC’s potential, even if we don’t have all of the details. Here’s what research has revealed so far:

  • Endocannabinoid inactivation is inhibited by CBC, which activates the transient receptor potential ankyrin-1.
  • CBC is a selective CB2 agonist.
  • TRPA1, TRPV1–4, and TRPV8 are TRP cation channels that CBC interacts with.
  • CB2 cells are activated by CBC in a dose-dependent manner, however, CB1 cells are not hyperpolarized.
  • CBC causes CB2 receptor internalization independent of GRK2/3 kinases by signaling through Gi/o type G proteins.

The following section expands on some of these topics and clarifies them.


No, CBC is non-psychoactive, which means that no amount of it will get you high.

THC binds to the CB1 receptor, resulting in the high that is associated with marijuana. Because CBC does not affect the CB1 receptor, it does not cause you to become high.

The effects are much more involved in mood & overall support of homeostasis, similar to CBD (a fancy word for balance).


Yes, hemp-derived CBC is now permitted in the United States because of the 2018 Farm Bill.

However, before you buy, double-check the rest of the ingredients. Because of how well these cannabinoids interact together, it’s typical for firms to mix delta 8 THC or delta 9 THC with CBC products.


So yet, there is no proof that CBC is harmful. Large doses of CBC were used in studies, which revealed a remarkable lack of side effects.

Researchers use the information on THC and CBD to determine the safety profile of CBC because hemp-derived cannabinoids are similar.

Marijuana has some negative consequences and risks (short-term memory loss, drug interactions, anxiety, etc.). Nonetheless, it is generally safe, and the benefits far exceed the risks, particularly when compared to other prescription drugs.

Because neither CBC nor CBD operate as antagonists to CB receptors but instead influence them in different ways, they are more comparable. CBD is safe and has shown remarkable potential in some areas, as well as being well-tolerated with few adverse effects.